Blood transcriptomic signatures in children with tuberculosis in a treatment-shortening trial
James A. Seddon, Vanessa Mwebaza Muwanga, Claire Dunican, Simon C. Mendelsohn et autres
0 citationsResearch Square
Anna Turkova
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
143Publications signalées
2649Citations signalées
4Affiliations récentes
Institutions déclarées
Domaines associés
HIV/AIDS drug development and treatmentHIV/AIDS Research and InterventionsTuberculosis Research and EpidemiologyHIV-related health complications and treatmentsHIV Research and Treatment
Publications récentes
A study testing new HIV treatment options for children and adolescents in Africa
Anna Turkova, Ellen Owen-Powell
0 citationshttp://isrctn.com/
Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial
Julia Bielicki, Michelle Clements, Victor Musiime, David P. Moore et autres
3 citationsThe Lancet
Blood transcriptomic signatures in children with tuberculosis in a treatment-shortening trial: Public, subject-level signature scores, RT-qPCR data, and metadata
Vanessa Muwanga, Claire Dunican, Simon C. Mendelsohn, Ortensia Vito et autres
0 citationsOpen University of Cape Town (University of Cape Town)
Blood transcriptomic signatures in children with tuberculosis in a treatment-shortening trial: Public, subject-level signature scores, RT-qPCR data, and metadata
Vanessa Muwanga, Claire Dunican, Simon C. Mendelsohn, Ortensia Vito et autres
0 citationsFigshare
Which trial do we need? Treatment of severe measles
Maroula Tritzali, Eleni Vergadi, Judith Breuer, A Bamford et autres
0 citationsClinical Microbiology and Infection
Computer-aided detection for radiological disease severity classification on chest radiograph in children with intra-thoracic tuberculosis
Megan Palmer, Iena Petronella Derks, H. Simon Schaaf, Pierre Goussard et autres
0 citationsPLOS Global Public Health
Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial
Hilda Angela Mujuru, Ellen White, Adeodata R Kekitiinwa, Abbas Lugemwa et autres
0 citationsOpen Forum Infectious Diseases
Predictors of Treatment Failure in Children With HIV Starting First-line Antiretroviral Therapy in the ODYSSEY Trial
James Wyncoll, Rujirek Kamolrattana, Moherndran Archary, Hilda A. Mujuru et autres
1 citationClinical Infectious Diseases
Bayesian analysis in confirmatory clinical trials: A narrative review and discussion of current practice
Rebecca Turner, Conor Tweed, Trinh Duong, D. J. Ford et autres
0 citationsClinical Trials
Weight gain, body composition, and metabolic parameters of dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: an ancillary analysis of the ODYSSEY trial
Anna Turkova, Ellen White, Avy Violari, Hilda A Mujuru et autres
2 citationsThe Lancet Child & Adolescent Health
Short Intensified Anti-Tuberculosis Therapy and Adjunctive Aspirin in Children and Adolescents with Tuberculous Meningitis: A Factorial, Randomised, Partially Blinded, Phase 3 Trial
Julie Huynh, Suzanne T. Anderson, Louise Choo, Varinder Singh et autres
0 citationsSSRN Electronic Journal
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.